L01AA09
PolandBendamustine
-
Bendamustine accord
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 25 mg/vial or 100 mg/vial ATC code: L01AA09
Manufacturer: Accompagny Healthcare Polska Ltd.
-
Bendamustine accord
Form: solution for infusion, concentrate
Active substance Dosage bendamustine hydrochloride monohydrate 26.14 mg/ml ATC code: L01AA09
Manufacturer: Accompagny Healthcare Polska Ltd.
-
Bendamustine eugia
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 2.5 mg/ml ATC code: L01AA09
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
Bendamustine glenmark
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 25 mg/vial or 100 mg/vial ATC code: L01AA09
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
Bendamustine kabi
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride 2.5 mg/ml ATC code: L01AA09
Manufacturer: Fresenius Kabi Deutschland GmbH
-
Bendamustine medac
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 26.1 mg ATC code: L01AA09
Manufacturer: medac GmbH for Clinical Special Preparations
-
Bendamustine zentiva
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 26.1 mg or 104.6 mg ATC code: L01AA09
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.